Neo Ivy Capital Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,290
| Closed | -$484K | – | 440 |
|
|
2023
Q2 | $484K | Buy |
+10,290
| New | +$484K | 0.26% | 128 |
|
|
2022
Q4 | $194K | Buy |
+5,094
| New | +$194K | 0.13% | 230 |
|
|
2021
Q3 | – | Sell |
-2,045
| Closed | -$116K | – | 611 |
|
|
2021
Q2 | $116K | Buy |
+2,045
| New | +$116K | 0.12% | 242 |
|
|
2021
Q1 | – | Sell |
-1,434
| Closed | -$124K | – | 607 |
|
|
2020
Q4 | $124K | Sell |
1,434
-2,861
| -67% | -$247K | 0.14% | 227 |
|
|
2020
Q3 | $262K | Buy |
+4,295
| New | +$262K | 0.27% | 138 |
|